Butane monooxygenase (BMO) catalyses the oxidation of alkanes to alcohols in the alkane-utilizing bacterium 'Pseudomonas butanovora'. Incubation of alkane-grown 'P. butanovora' with butyrate or propionate led to irreversible time-and O 2 -dependent loss of BMO activity. In contrast, BMO activity was unaffected by incubation with lactate or acetate. Chloramphenicol inhibited the synthesis of new BMO, but did not change the kinetics of propionate-dependent BMO inactivation, suggesting that the propionate effect was not simply due to it acting as a repressor of BMO transcription. BMO was protected from propionate-dependent inactivation by the presence of its natural substrate, butane. Although both the time and O 2 dependency of propionate inactivation of BMO imply that propionate might be a suicide substrate, no evidence was obtained for BMO-dependent propionate consumption, or 14 C labelling of BMO polypeptides by [2-
INTRODUCTION
Bacterial monooxygenase enzymes have been extensively studied because of their potential to degrade environmental pollutants, and to serve as biocatalysts for the creation of industrially important chemicals (Astier et al., 2003; Lipscomb, 1994; Smith et al., 2003; Smith & Dalton, 2004) . In this connection we have studied the transcriptional and physiological regulation of butane monooxygenase (BMO) in 'Pseudomonas butanovora'. BMO oxidizes n-alkanes C 2 to C 9 to alcohols, which are subsequently metabolized to fatty acids (Arp, 1999; Doughty et al., 2006) . We have shown that the activity of the bmo promoter is induced by alcohol, aldehyde and epoxide products of alkane and alkene oxidation, and repressed by micromolar concentrations of propionate (Doughty et al., 2005 (Doughty et al., , 2006 Sayavedra-Soto et al., 2001 , 2005 . Furthermore, although the organic acids acetate, propionate, butyrate and lactate can act as exogenous sources of reductant to stimulate BMO activity, propionate and butyrate do not sustain linear rates of BMO activity for as long as equivalent amounts of lactate or acetate (Doughty et al., 2005) . In this study our observations were extended to show that propionate and butyrate inactivate pre-existing BMO.
BMO shares a high level of amino acid sequence identity with the well-characterized soluble methane monooxygenase (sMMO) found in methanotrophic bacteria (Sluis et al., 2002) . Inhibitors and inactivators of sMMO include (i) suicide substrates such as terminal alkynes, which covalently bind to active-site residues following a catalytic transformation in the enzyme's active site ; (ii) heavy metals (e.g. Cu
2+
) that rapidly and irreversibly inhibit the reductase subunit of the enzyme, preventing electron transfer to the hydroxylase subunit (Green et al., 1985; Jahng & Wood, 1996) ; and (iii) H 2 O 2 , which inactivates the enzyme through an unknown mechanism (Astier et al., 2003) . Because propionate lacked structural similarity to any of the known inhibitors and inactivators of sMMO mentioned above, we thought it worthwhile to characterize the effect of propionate on BMO. As the project evolved, it became clear that intermediate chain-length fatty acids might be potentially useful for further studies focused on dissecting the catalytic mechanism of BMO.
METHODS
Bacterial strains, growth conditions and enzyme assays. Wildtype and mutant strains of 'P. butanovora' (ATCC 43655) were grown as described previously (Arp, 1999; Hamamura et al., 1999; Vangnai & Arp, 2001 ). Cells were harvested by sedimentation in a centrifuge (6500 g for 10 min), and washed three times in 50 mM sodium/ potassium phosphate buffer, pH 7.1. Lactate-supported, ethenedependent ethene oxide production is a convenient measure of BMO activity. Ethene oxide assays were performed as described previously (Doughty et al., 2005) except that 0.5 ml samples of the headspace were taken at 2.5 min intervals and injected into separate 7 ml sealed vials for later analysis. This variation of the assay allowed for the prompt sampling of a large number of vials and separated experimental execution from the analysis of gas samples. Protein concentrations were determined using the micro-biuret assay described previously (Gornall et al., 1949) .
In vivo inactivation of BMO in 'P. butanovora'. Butane-grown cultures of 'P. butanovora' were harvested and washed as described above. Vials (160 ml) containing 80 ml of cells (OD 600 0.5; 0.2 mg protein ml
21
), resuspended in 50 mM sodium/potassium phosphate buffer, served as the reaction chambers for the assays. Vials received 10 mM lactate as an exogenous reductant to support BMO activity and 10 mM of either propionate, butyrate or acetate. Assay mixtures were shaken on an orbital shaker at 200 r.p.m. and 30 uC. Accurate assessment of time-dependent inactivation of BMO required the prompt interruption of the assay. To accomplish this, aliquots of cells were injected into 'stop vials' (160 ml) containing 10 ml 50 mM sodium/ potassium phosphate buffer in equilibrium with headspace containing 0.4 mmol butane gas (approx. 200 mM aqueous concentration), which prevented further inactivation of the BMO enzyme during the washing procedure. Cells were washed three times by centrifugation (6500 g for 10 min), resuspended in 50 mM sodium/ potassium phosphate buffer, and tested for residual BMO activity using the lactate-dependent ethene oxidation assay described above.
Because substrate oxidation by BMO is dependent upon O 2 as a cosubstrate, we also examined the effect of propionate on BMO under anoxic conditions. Vials (160 ml) containing 30 ml of 50 mM sodium/potassium phosphate buffer were sealed with butyl rubber stoppers and made anoxic by flushing the headspace with argon for 2 min. Stock solutions of lactate and propionate, as well as cell suspensions, were prepared using the same method. Lactate (10 mM), propionate (10 mM) and cell suspensions were injected into the reaction vial with an airtight syringe. Aliquots were removed from each treatment and injected into 'stop' vials, washed three times, and tested for BMO activity as described earlier.
Investigation of propionate-dependent inactivation in mutant strains of 'P. butanovora' with modified BMO hydroxylase.
Amino acid sequence alignments were used to compared the hydroxylase subunit of BMO with the hydroxylase subunit (MMOH) of the well-characterized sMMO enzymes of Methylococcus capsulatus (Bath) and Methylosinus trichosporium OB3b (Halsey et al. 2006) . Amino acid residues were identified that were likely associated with (a) the active site, (b) entry of substrate into the active site, or (c) the interaction between the hydroxylase subunit and a regulatory subunit, BmoB. These amino acid residues were targeted for site-directed mutagenesis and are described in Table 1 . The mutants were screened for sensitivity to propionate as described above. (Sambrook et al., 1989) . Protein (20 mg) from each treatment was loaded onto a 12.5 % Table 1 . Summary of mutant strains of 'P. butanovora' in which single amino acid substitutions were made to the a-subunit of the BMO hydroxylase (BMOH)
For further details of mutants see Halsey et al. (2006) .
Strain
Targeted amino acid in BMOH-a* Because complete inactivation of BMO did not occur following incubation with propionate, an experiment was carried out to discriminate between inactivation of a fraction of BMO versus a reduced turnover rate by all BMO molecules. The effect of propionate inactivation on 14 C 2 H 2 label incorporation into BMO was examined. Butane-grown cells, washed and treated as described above, were exposed to either 10 mM lactate or 10 mM lactate plus 10 mM propionate for 2 h. Cells were washed and aliquots of each treatment were tested for BMO activity or incubated with 10 mM lactate plus 14 C 2 H 2 for 2 h. Following incubation with 14 C 2 H 2 , whole-cell protein was examined by SDS-PAGE and the incorporation of 14 C into the asubunit polypeptide of BMO hydroxylase determined as described above.
Propionate inactivation of monooxygenases from other bacteria. Burkholderia cepacia G4 and Pseudomonas mendocina KR-1 were grown in the same medium as described for 'P. butanovora' with toluene (1 mM) as the carbon source. Cultures were shaken at 200 r.p.m. on an orbital shaker at 30 uC. The methanotrophic bacteria Methylosinus trichosporium OB3b and Methylococcus capsulatus (Bath), were grown under copper-limiting conditions in a KNO 3 minimal salts medium to promote the production of sMMO rather than pMMO (Lee et al., 2006; Whittenbury et al., 1970) . M. capsulatus (Bath) was incubated at 37 uC and M. trichosporium OB3b was incubated at 30 uC on an orbital shaker at 200 r.p.m. Monooxygenase activity was monitored with the ethene oxide assay described above.
RESULTS
In vivo organic-acid-dependent inactivation of BMO Doughty et al. (2005) showed previously that acetate, propionate and butyrate are effective exogenous sources of reductant for supporting BMO activity in propane-grown cells of 'P. butanovora'. In this work it can be clearly seen that propionate (10 mM) or butyrate (10 mM) quickly and effectively reduced lactate-dependent BMO activity (Fig. 1) . In contrast, the rate of lactate-dependent BMO activity was not affected when acetate (10 mM) or an equivalent volume of phosphate buffer was added to the assay. The kinetics of propionate inactivation of BMO were unchanged even at concentrations as low as 0.1 mM, suggesting that the effect of propionate on BMO reaches saturation at concentrations below 0.1 mM. The same organic acids were tested to determine if the BMO inactivation was reversible or irreversible (Fig. 2) . Propionate and butyrate irreversibly inactivated BMO in a time-dependent manner, and BMO activity was not completely restored when propionate or butyrate were removed (Fig. 2) . In contrast, BMO activity did not decrease in cells treated with either lactate or a combination of lactate and acetate. From data in Fig. 1 it was calculated that propionate had reduced BMO activity by 73-80 % of its initial rate between 5 and 7.5 min after propionate addition. In contrast, Fig. 2 shows that only 40 % of BMO was irreversibly inactivated following a similar length of incubation with propionate. These data suggest that propionate acts as both a reversible inhibitor and irreversible inactivator of BMO. The remainder of this study focused on the irreversible effect of propionate on BMO activity.
The presence of butane and the absence of O 2 protect BMO activity from the effect of propionate A series of experiments was carried out to characterize propionate-dependent BMO inactivation. When butane (0.2 mM) was present in the assay, propionate (10 mM) did not lead to a significant loss of BMO activity (Fig. 3a) . Because BMO hydroxylation of butane is dependent upon O 2 as a co-substrate we thought it worthwhile to determine if O 2 was required for propionate-dependent BMO inactivation. Under anoxic conditions, propionate (10 mM) failed to inactivate BMO (Fig. 3b) . In contrast, when 22 nmol O 2 was supplied to anoxic cells, the ability of propionate to inactivate BMO was restored. Control treatments which received either no O 2 , or O 2 and no propionate, did not show a significant decrease in BMO activity. Propionate-inactivated BMO did not regain activity following subsequent incubation under anoxic conditions, indicating that BMO activity was protected by anoxia, rather than restored during anoxic treatment. The O 2 -dependence of inactivation suggests that the catalytic cycle of BMO is involved in propionate-dependent inactivation.
Determining the effect of protein synthesis on BMO activity
Because the relative rates of BMO synthesis and turnover are unknown, we explored the possibility that propionatedependent BMO inactivation was due to repression of BMO synthesis. Chloramphenicol (50 mg ml 21 ) prevented the induction of BMO in repressed lactate-grown cells that were exposed to butane (data not shown). The kinetics of propionate-dependent inactivation of BMO were the same in chloramphenicol-treated and control cells, indicating that the decrease in BMO activity following exposure to propionate was mediated on pre-existing BMO.
[2- Because propionate did not completely inactivate BMO, we attempted to distinguish between reduced BMO activity being due to inactivation of a fraction of BMO molecules versus a reduced rate of turnover of all BMO molecules. Butane-grown cells incubated with propionate for 2 h retained~10 % of BMO activity, and all remaining BMO activity was found to be acetylene sensitive (Fig. 4a, b) . Furthermore, the incorporation of 14 C from 14 C 2 H 2 into the 58 kDa polypeptide of the a-subunit of BMO hydroxylase was reduced by~90 % relative to the buffer control, and was consistent with the propionate-dependent reduction of BMO activity (Fig. 4c) . These data suggest that propionate caused BMO inactivation rather than an overall reduction in the rate of BMO turnover.
Inactivation of BMO in 'P. butanovora' mutants strains containing specific amino acid substitutions in the a-subunit of the BMO hydroxylase Mutant strains of 'P. butanovora' that contain single amino acid substitutions in the a-subunit of BMO hydroxylase (BMOH-a) were examined for propionate-dependent inactivation of BMO (Table 2 ). The effects of propionate on BMO differed among the mutant strains. For example, in the case of the G113N mutant, in which a glycine was replaced by an asparagine residue in a region adjacent to, or contributing to, the active site, BMO activity was not inactivated by propionate. In contrast, mutant strain T148C, in which a threonine in the active-site region was replaced by a cysteine, showed a significant increase in propionate-dependent inactivation of BMO relative to wild-type. Mutants F321Y and L279F, which were modified at amino acid positions believed to be involved in the interaction of BMOH-a with BMOB, were inactivated by propionate to a similar extent as wild-type. Interestingly, reversible inhibition of BMO was observed in all mutant strains, including the G113N mutant. Inhibition of BMO activity by propionate in the G113N mutant was timedependent, and a 10 min incubation with propionate was sufficient to inhibit~50 % of BMO activity. Propionatetreated G113N mutant regained BMO activity equivalent to the untreated cells following the washing procedure.
Survey of other monooxygenases for propionatedependent inactivation
We explored the possibility that other well-studied monooxygenase enzymes that are closely related to BMO might be inactivated by fatty acids. In vivo studies showed that the diiron methane monooxygenases (sMMO) of Methylococcus capsulatus Bath and Methylosinus trichosporium OB3b, and the toluene o-monooxygenase of Burkholderia cepacia G4, were not inactivated by propionate. In contrast, the toluene 4-monooxygenase (T 4 MO) of Pseudomonas mendocina KR1 was inactivated following a C 2 H 2 -dependent labelling of the asubunit of the BMO enzyme in cells treated as described in (a), washed, and treated for 2 h with 14 C 2 H 2 . DValues represent the mean of three replicates; the standard deviations of the means are shown in parentheses. dCells were incubated in 50 mM phosphate buffer with 10 mM lactate for 30 min. §Cells were incubated in 50 mM phosphate buffer with 10 mM lactate and 10 mM propionate for 30 min.
10 min incubation with 10 mM propionate or butyrate by about 60 and 94 % respectively. In contrast, acetate or lactate did not inactivate T 4 MO activity, indicating that T 4 MO was sensitive to the same range of organic acids as BMO. Furthermore, T 4 MO activity was protected from propionate-dependent inactivation by toluene, the physiological substrate of T 4 MO (data not shown).
DISCUSSION
The current study provided an unexpected and novel finding, that intermediate chain-length fatty acids inactivate BMO. Because some, but not all, of the BMO activity could be recovered when cells were washed to remove propionate, we were able to provide convincing evidence that both reversible inhibition and inactivation of BMO occurred. Furthermore, propionate-dependent inactivation of BMO was not observed in one mutant strain of 'P. butanovora' in which glycine 113 (thought to be close to the catalytic site on the a-subunit of BMO hydroxylase) was changed to an asparagine residue. Because the reversible inhibition by propionate remained unaffected in this mutant, these data indicated that reversible inhibition and irreversible inactivation of BMO occur through separate mechanisms.
Propionate inhibition of BMO ties in well with the recent discovery that propionate represses the transcription of BMO genes (Doughty et al., 2006) . We previously discussed a model of BMO transcriptional regulation to explain how fatty acid products of alkane oxidation might repress BMO. This form of feedback inhibition resembles the regulation of lipid synthesis (Fab) and fatty acid oxidation (Fad) characterized in Escherichia coli (Cronan & Subrahmanyam, 1998) . In this connection it is interesting to note that three Fab enzymes are not only repressed by long-chain acyl-CoAs at the level of transcription, but also controlled post-translationally through feedback inhibition by acylated acyl-carrier proteins (acyl-ACP) (Heath & Rock, 1996; Marrakchi et al., 2002) . The net result is close coupling of the reductant-consuming lipid biosynthesis pathway with reductant-generating fatty acid b-oxidation. Similarly, the inhibition of alkane oxidation by the downstream products of BMO activity could prevent the allocation of reductant to BMO under circumstances where the production of fatty acids via alkane oxidation exceeds the carbon and energy requirements of the cell. A physiological role for inactivation of BMO can also be envisaged, particularly if the monooxygenase turns over slowly, generates toxic H 2 O 2 in the absence of substrate, and also continues to consume reductant.
Because we could not detect propionate consumption during BMO inactivation, and [2-
14
C]propionate label did not associate with the BMO polypeptides after electrophoresis under denaturing conditions, propionate inactivation did not follow the model of a monooxygenase suicide substrate such as acetylene. In the context of existing literature on sMMO, two possible mechanisms for propionate-dependent inactivation of BMO can be proposed. First, in vitro studies showed that when sMMO hydroxylase is electrically reduced at the surface of an electrode, O 2 is reduced to H 2 O 2 by the hydroxylase and subsequently inactivates it (Astier et al., 2003) . We propose a model of BMO inactivation in which propionate stimulates the production of H 2 O 2 by BMO and causes oxidative enzyme damage. Propionate-dependent formation of H 2 O 2 by BMO would reconcile our observations that BMO inactivation is O 2 -and turnover-dependent, while propionate oxidation per se does not occur. A model based upon the catalytic cycle of sMMO is shown in Fig. 5 (Brazeau et al., 2001; Lee et al., 1993a, b; Liu et al., 1995; Zhang & Lipscomb, 2006) . The diferric active site, shown at the bottom of the model, is reduced and used to break one bond of O 2 , forming intermediate P. The scission of the second O 2 bond results in the formation of intermediate Q. Alternatively, the reaction of the reduced form of sMMO with O 2 can result in H 2 O 2 formation and a return of sMMO to a diferric resting state (Zhang & Lipscomb, 2006) . Although the presence of the regulatory subunit (MMOB) eliminates the production of H 2 O 2 by sMMO hydroxylase, H 2 O 2 production resumed, as did enzyme inactivation, following the introduction of substrate to the reaction mixture (Astier et al., 2003) . In this context, the aliphatic tail of propionate might resemble the alkane substrate of BMO sufficiently well to reduce the coupling of O 2 activation to substrate oxidation and result in H 2 O 2 formation. In this connection there is some indication that BmoB is not involved in the coupling of O 2 activation to substrate turnover by BMO (Dubbels et al., 2007) . In methane monooxygenase hydroxlyase (MMOH), multiple substrate-binding sites have been proposed for substrates larger than methane (Sazinsky & Lippard, 2005) , raising the possibility that butane and propionate compete Fig. 5 . A model of propionate-dependent inactivation of BMO superimposed upon the catalytic cycle of sMMO (Brazeau et al., 2001) . See text for details.
for a site outside the substrate-binding pocket. Conceptually, this could reconcile our observations that (i) butane protects BMO from propionate and (ii) propionate is not oxidized by BMO (as propionate does not enter the active site). Our results, although preliminary, raise the possibility that alternative substrate-binding pockets have replaced the role of the coupling subunit in substrate recognition. Second, propionate may form an ionic bond with the active-site irons, and inactivate the enzyme by blocking the active site. In this context, it is interesting to note that crystallographic data obtained from the diferric form of sMMO showed an unidentified electron density within the hydrophobic substrate-binding pocket. Researchers tentatively identified this structure as acetate, a component of the crystallization buffer, with the carboxyl group of acetate forming a bridging ligand between the diirons (Rosenzweig et al., 1997) . Additionally, recent research on a structurally related diiron desaturase used acetate as a molecular mimic for O 2 binding. The authors suggested that acetate produced a carboxyl shift in a glutamate residue, resulting in a change in coordination of an active-site iron (Moche et al., 2003) . Interestingly, a similar change was observed following the binding of substrate (acyl-ACP) and it is hypothesized that the observed change in iron coordination increases the reactivity of the active site with O 2 (Moche et al., 2003) . Our research, although preliminary and in vivo, raises the possibility that propionate could be useful as a probe to uncover some of the mechanistic details of BMO. Because of the novelty of propionate-dependent inactivation, we extended our study to mutant strains of 'P. butanovora' in which single amino acid substitutions had been made to the a-subunit of the hydroxylase (Halsey et al., 2006) . Because amino acids G113 and T148 are predicted to be close to the enzyme active site (Table 1) , the altered outcome of propionate inactivation observed in mutant strains G113N and T148C suggests that propionate enters the active site of BMO. Although it remains unclear why mutant strains G113N and T148C display altered propionate-dependent inactivation relative to wild-type, two possibilities can be discussed. First, structural prediction programs indicate that the size of the hydrophobic substrate-binding cavity of BMO will be decreased by the GAN mutation and increased by the TAC mutation (Halsey et al., 2006) . In this context, the insensitivity of mutant strain G113N to propionate may indicate that the active site of the enzyme is inaccessible to propionate. In contrast, the larger substrate-binding cavity of T148C may increase the accessibility of the active site to propionate. Second, the altered outcome of propionate-dependent inactivation in the mutant strains might reflect a subtle change in the tendency of these enzymes to release H 2 O 2 . Indeed, recent research on a structurally related diiron desaturase indicated that a mutant form of the enzyme containing a single amino acid substitution near the active site produced 40-fold more H 2 O 2 than the wild-type enzyme (Guy et al., 2006) . Clearly, we are in a position to move forward and obtain crystal structures of BMO from both the wild-type and mutant strains, and carry out in vitro studies with the recently purified BMO (Dubbels et al. 2007) to gain a better understanding of short-chain fatty acid inactivation.
